| Dr Ralph Paul Ferenchak, MD | |
|
1676 Sunset Ave, Utica, NY 13502-5416 | |
| (315) 624-5226 | |
| (315) 624-5279 |
| Full Name | Dr Ralph Paul Ferenchak |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1676 Sunset Ave, Utica, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881826956 | NPI | - | NPPES |
| 00570489 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 116774 (New York) | Secondary |
| 207Q00000X | Family Medicine | 116774 (New York) | Primary |
| Entity Name | Faxton-st Lukes Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770690737 PECOS PAC ID: 2769380252 Enrollment ID: O20031222000433 |
News Archive
A congressional delegation "met Thursday with Zimbabwean President Robert Mugabe and Finance Minister Tendai Biti to discuss progress in fully implementing the September 2008 Global Political Agreement for power sharing and on reforms by the Harare unity government," VOA News reports (Zulu, 2/18).
Medicare patients nationwide have low rates of preventive care visits – with the lowest rates found in older adults of minority race/ethnicity, reports a study in the September issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Blood pressure has been measured and recorded in the same way for nearly a century. This is set to change. Researchers believe that the earlier way has led to the misdiagnosis of many. This could be due to a phenomenon called "white coat hypertension" or rise in the blood pressure due to nervousness on meeting the medical staff. It is seen that at least 25% of the population suffers from white coat hypertension.
OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September. Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.
Cephalon, Inc. has announced positive results from a phase two clinical trial of NUVIGIL(R) (armodafinil) Tablets [C-IV] as adjunctive therapy for treating major depressive disorder in adults with bipolar I disorder.
› Verified 1 days ago
| Entity Name | Empire Wound Physician Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093130742 PECOS PAC ID: 6406170497 Enrollment ID: O20150122001257 |
News Archive
A congressional delegation "met Thursday with Zimbabwean President Robert Mugabe and Finance Minister Tendai Biti to discuss progress in fully implementing the September 2008 Global Political Agreement for power sharing and on reforms by the Harare unity government," VOA News reports (Zulu, 2/18).
Medicare patients nationwide have low rates of preventive care visits – with the lowest rates found in older adults of minority race/ethnicity, reports a study in the September issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Blood pressure has been measured and recorded in the same way for nearly a century. This is set to change. Researchers believe that the earlier way has led to the misdiagnosis of many. This could be due to a phenomenon called "white coat hypertension" or rise in the blood pressure due to nervousness on meeting the medical staff. It is seen that at least 25% of the population suffers from white coat hypertension.
OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September. Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.
Cephalon, Inc. has announced positive results from a phase two clinical trial of NUVIGIL(R) (armodafinil) Tablets [C-IV] as adjunctive therapy for treating major depressive disorder in adults with bipolar I disorder.
› Verified 1 days ago
| Entity Name | New York General Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700315538 PECOS PAC ID: 7810255494 Enrollment ID: O20180103003151 |
News Archive
A congressional delegation "met Thursday with Zimbabwean President Robert Mugabe and Finance Minister Tendai Biti to discuss progress in fully implementing the September 2008 Global Political Agreement for power sharing and on reforms by the Harare unity government," VOA News reports (Zulu, 2/18).
Medicare patients nationwide have low rates of preventive care visits – with the lowest rates found in older adults of minority race/ethnicity, reports a study in the September issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Blood pressure has been measured and recorded in the same way for nearly a century. This is set to change. Researchers believe that the earlier way has led to the misdiagnosis of many. This could be due to a phenomenon called "white coat hypertension" or rise in the blood pressure due to nervousness on meeting the medical staff. It is seen that at least 25% of the population suffers from white coat hypertension.
OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September. Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.
Cephalon, Inc. has announced positive results from a phase two clinical trial of NUVIGIL(R) (armodafinil) Tablets [C-IV] as adjunctive therapy for treating major depressive disorder in adults with bipolar I disorder.
› Verified 1 days ago
| Entity Name | Nv Pacs 2 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427534809 PECOS PAC ID: 0941550578 Enrollment ID: O20210831002021 |
News Archive
A congressional delegation "met Thursday with Zimbabwean President Robert Mugabe and Finance Minister Tendai Biti to discuss progress in fully implementing the September 2008 Global Political Agreement for power sharing and on reforms by the Harare unity government," VOA News reports (Zulu, 2/18).
Medicare patients nationwide have low rates of preventive care visits – with the lowest rates found in older adults of minority race/ethnicity, reports a study in the September issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Blood pressure has been measured and recorded in the same way for nearly a century. This is set to change. Researchers believe that the earlier way has led to the misdiagnosis of many. This could be due to a phenomenon called "white coat hypertension" or rise in the blood pressure due to nervousness on meeting the medical staff. It is seen that at least 25% of the population suffers from white coat hypertension.
OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September. Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.
Cephalon, Inc. has announced positive results from a phase two clinical trial of NUVIGIL(R) (armodafinil) Tablets [C-IV] as adjunctive therapy for treating major depressive disorder in adults with bipolar I disorder.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ralph Paul Ferenchak, MD 5695 Bull Hill Rd, La Fayette, NY 13084-9779 Ph: (315) 510-2061 | Dr Ralph Paul Ferenchak, MD 1676 Sunset Ave, Utica, NY 13502-5416 Ph: (315) 624-5226 |
News Archive
A congressional delegation "met Thursday with Zimbabwean President Robert Mugabe and Finance Minister Tendai Biti to discuss progress in fully implementing the September 2008 Global Political Agreement for power sharing and on reforms by the Harare unity government," VOA News reports (Zulu, 2/18).
Medicare patients nationwide have low rates of preventive care visits – with the lowest rates found in older adults of minority race/ethnicity, reports a study in the September issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Blood pressure has been measured and recorded in the same way for nearly a century. This is set to change. Researchers believe that the earlier way has led to the misdiagnosis of many. This could be due to a phenomenon called "white coat hypertension" or rise in the blood pressure due to nervousness on meeting the medical staff. It is seen that at least 25% of the population suffers from white coat hypertension.
OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September. Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.
Cephalon, Inc. has announced positive results from a phase two clinical trial of NUVIGIL(R) (armodafinil) Tablets [C-IV] as adjunctive therapy for treating major depressive disorder in adults with bipolar I disorder.
› Verified 1 days ago
Virendra Sharma, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Hobart St, Utica, NY 13501 Phone: 315-798-1149 Fax: 315-734-3565 | |
Dr. Robert Karl Chruscicki, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 288 Genesee Street, Utica, NY 13502 Phone: 315-724-7744 | |
Julie Betro Shkane, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Hobart St, Utica, NY 13501 Phone: 315-798-1149 Fax: 315-734-3565 | |
Emily Hsu Joslin, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 Hobart St, Utica, NY 13501 Phone: 315-797-1149 Fax: 315-734-3565 | |
Molly Schug, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1256 Culver Ave, Utica, NY 13501 Phone: 315-798-7186 Fax: 315-738-0188 | |
Mahesh Padmanabhan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 120 Hobart St, Utica, NY 13501 Phone: 315-798-1149 Fax: 315-734-3565 | |
Sun Yoo, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 120 Hobart St, Utica, NY 13501 Phone: 315-798-1149 Fax: 315-734-3565 |